Lee Pharmaceuticals
This article was originally published in The Rose Sheet
Executive Summary
Net revenue for the third quarter (ended June 30) advanced 11% to $2.2 mil. fueled by the performance of depilatory and OTC brands as well as new private label business, personal care manufacturer announces Aug. 14. Increases partially were offset by lower sales of Lip-Ex lip balms and Lee nail products, firm notes. Lee experienced net loss of $167,000 for period. Company also manufactures Bikini Bare and Zip depilatories...